Search research articles
Contact Us
Filters
Showing results (281-290 of 387) with videos related to
Page
of 39
Sort By:
Cell
|
October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
Matthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
Archives of Pathology & Laboratory Medicine
|
July 25, 2019
Predictive Markers Require Thorough Analytic Validation
Megan L Troxell, Regan S Fulton, Paul E Swanson, et al.
Cell
|
November 17, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
Matthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 31, 2020
Remethylation of <i>Dnmt3a</i><sup>-/-</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing
Shamika Ketkar, Angela M Verdoni, Amanda M Smith, et al.
Blood
|
December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
Terrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight
|
March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Meagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Nature Genetics
|
February 22, 2011
The draft genome of the parasitic nematode Trichinella spiralis
Makedonka Mitreva, Douglas P Jasmer, Dante S Zarlenga, et al.
Cell
|
November 24, 2014
Sequencing the mouse Y chromosome reveals convergent gene acquisition and amplification on both sex chromosomes
Y Q Shirleen Soh, Jessica Alföldi, Tatyana Pyntikova, et al.
Cell
|
February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression
David H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Cell Reports
|
September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas
Obi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.
Page
of 39
Search research articles
Search
Showing results (281-290 of 387) with videos related to
Sort By:
Page
of 39
Cell
|
October 23, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
Matthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
Archives of Pathology & Laboratory Medicine
|
July 25, 2019
Predictive Markers Require Thorough Analytic Validation
Megan L Troxell, Regan S Fulton, Paul E Swanson, et al.
Cell
|
November 17, 2018
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
Matthew M Gubin, Ekaterina Esaulova, Jeffrey P Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 31, 2020
Remethylation of <i>Dnmt3a</i><sup>-/-</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing
Shamika Ketkar, Angela M Verdoni, Amanda M Smith, et al.
Blood
|
December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
Terrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight
|
March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Meagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Nature Genetics
|
February 22, 2011
The draft genome of the parasitic nematode Trichinella spiralis
Makedonka Mitreva, Douglas P Jasmer, Dante S Zarlenga, et al.
Cell
|
November 24, 2014
Sequencing the mouse Y chromosome reveals convergent gene acquisition and amplification on both sex chromosomes
Y Q Shirleen Soh, Jessica Alföldi, Tatyana Pyntikova, et al.
Cell
|
February 21, 2017
CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression
David H Spencer, David A Russler-Germain, Shamika Ketkar, et al.
Cell Reports
|
September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas
Obi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.
Page
of 39